First participants imaged in SAR-Bombesin prostate cancer trial in Australia
Sydney, Australia 14 September 2022 Highlights First participants were recruited and imaged in the diagnostic investigator-initiated trial (IIT) led by Prof Louise Emmett at St Vincent’s Hospital Sydney with one of Clarity’s core products, SAR-Bombesin The Phase II IIT builds on the data generated in PSMA-negative prostate cancer patients imaged at St Vincent’s Hospital under…